Karachi September 16 2022: GlaxoSmithKline Consumer confirmed the recent news about the raid to one of their warehouses.
However, company firmly reject the claims related to the hoarding of Panadol intentionally to create shortage. The stocks at this warehouse were intended to be released and distributed in the country in the normal course of business.
“As GlaxoSmithKline Consumer Healthcare Pakistan Limited (member of the Haleon group), we are led by our purpose of delivering everyday health with humanity. This has been shown through our commitment to the people of Pakistan throughout challenging times.” says Mr. Farhan Muhammad Haroon Chief Executive Officer.
GSK continue to supply Panadol products in the country and have adjusted our production capacity to ensure some product availability, despite market obstacles.
Related Posts
